Main content
ROADMAP - Real world Outcomes across the Alzheimer’s Disease spectrum for better care: Multi-modal data Access Platform
Date created: | Last Updated:
: DOI | ARK
Creating DOI. Please wait...
Category: Project
Description: The “Real world Outcomes across the Alzheimer’s Disease spectrum for better care: Multi-modal data Access Platform” (ROADMAP) project aimed to provide the foundation for an integrated data environment and framework for real-world evidence (RWE in Alzheimer’s disease). This included the development of consensual key outcome measures and enabling data integration tools for dataset characterisation and outcome classification, as well as guidelines on the handling and interpretation of RWE data. ROADMAP had a budget of EUR 8.21 million and 26 partners led by the University of Oxford and Novartis. The project ran from September 2016 till October 2018. This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 116020 (“ROADMAP”). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. Questions about the project can be directed to: info@roadmap-alzheimer.org
Add important information, links, or images here to describe your project.